The State of Nebulizer Therapy in Russian Federation

Respiratory Failure Clinical Trial

— SoNeT  

Official title:

The State of Nebulizer Therapy in Russian Federation: a National Survey Among Medicine Physicians

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05617079
• Other study ID #: FARCT0004
• Status: Recruiting
• Start date: July 1, 2023
• Est. completion date: July 31, 2024

Study information

• Verified date: February 2024
• Source: Russian Federation of Anesthesiologists and Reanimatologists
• Contact: Alexey Gritsan, MD
• Phone: +79039205304
• Email: gritsan67[@]mail.ru
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

It is known that the inhalation (nebulizer) use of drugs is of great importance in the intensive care of patients with acute and chronic respiratory failure of various origins.

Searching PubMed data for the last 5 years (2017-2022) for the keywords "nebulizer therapy" revealed 533 publications, and "mesh nebulizer therapy" - only 25 sources.

During the same period, the national database (E-Library) has 75 publications for the keywords "nebulizer therapy", and 4 sources for "mesh nebulizer therapy".

It should be noted that almost all publications are devoted to the use of nebulizers for specific diseases and pathological syndromes. There are no works evaluating the adherence of specialists, systemic indications and actually used methods.

The aim of trial is to study the current state of the use of nebulizer therapy in medical organizations and identify ways to improve its effectiveness This study is planned to be carried out using a questionnaire using a database based on the Internet electronic survey form.

Description:

We intend to involve at least 3 medical organizations in the subjects of the Russian Federation with a population of up to 1 million people; at least 5 medical organizations in the constituent entities of the Russian Federation with a population level of 1 to 3 million people, at least 7 organizations with a population level of more than 3 million people. In cities of the Russian Federation with a population of 1 million people or more - at least 5 medical organizations, and in the cities of Moscow and St. Petersburg - at least 10 medical organizations.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 370
• Est. completion date: July 31, 2024
• Est. primary completion date: June 30, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Medical physicians

Exclusion Criteria:

• Lack of experience in conducting nebulizer therapy. Lack of technical capability for nebulizer therapy in a medical organization.

Related Conditions & MeSH terms

• Respiration Disorders
• Respiratory Disease
• Respiratory Failure
• Respiratory Insufficiency
• Respiratory Tract Diseases
• Survey

Intervention

Other:
• Survey
an electronic survey will be conducted

Locations

Country	Name	City	State
Russian Federation	Alexey Gritsan	Krasnoyarsk

Sponsors (1)

Lead Sponsor	Collaborator
Russian Federation of Anesthesiologists and Reanimatologists

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Structure of indications, methods and frequency of use of nebulizer therapy	Registration of the structure and indications for nebulizer therapy	up to 1 month after inclusion
Secondary	Drugs and frequency of their use during nebulizer therapy	Registration of drugs used for nebulizer therapy	up to 6 month after inclusion
Secondary	The frequency of use of nebulizer therapy for high-flow oxygen therapy, non-invasive ventilation and mechanical ventilation	Frequency of use of nebulizer therapy for various types of respiratory support	up to 6 month after inclusion